Chapter 17 Flashcards
A) Type I hypersensitivities involve what type of antibody? [IgE mediated Type I hypersensitivity video]
Ige which binds to mast cells or basophils
B) What is sensitization? [Figure 17.1]
begins when a allergen induces antibody response.
IgE begins to be produced by the B cells and then the IgE molecules then attatch to basophils and mast cells and so when an allergen come in contact it illicits a response
C) What is the process of degranulation?
when spegific 2 mast cell’s IgE’s sense an allergen then they will come together and cross link. This results in histamine and other inflamatory mediators.
D) What causes the classic allergy symptoms?
degranulation: histamine= vaso dialations and bronchiolconstriction
E) What are hives? How is it identified? When do they occur?[Figure 17.2]
urticara: characterized by wheel(swelling) and flare(redness)
mast cells degranulate releaseing histamine causing the swelling
F) What are the symptoms of hay fever and when does it occur?
rhinitis: itching, teary eyes, sneezing. from airborne antigens
G) What causes asthma? How is it treated?
degranulation and release inflamatory mediators into the lower respiratory system. These mediators incled leukotrines and prostoglandins which cause bronchospasms and increased mucous production.
Treatment: Bronchodialators ie cortison like steroids. anti IgE therapy for prevention
H) What is systemic anaphylaxis and what can cause it?
antigen enters blood stream and spread throughout. the IgE’s on basophils release their inflamatory mediators into blood stream resulting in a bp drop.
bee stings, peanuts, and penicillin injections.
I) What is Immunotherapy used for?
alters immune responses and decrease the negative feedback.
J) What is desensitization and how does it work?[Figure 17.3]
injecting people with the diluted allergen and slowly increase it. This helps IgG’s to form and out compete the IgE’s.
K) What is the medication omalizuMab used for?
prevents IGE’s from binding to mast cells. this causes the IgG’s toFc portion of the IgE’s which prevents them from attatching to mast cells and basophils.
L) What are rhuMab’s?
q ????
A) What happens during a type II hypersensitivity reaction?
this is when the antibodies react with molecules on the surface of the cell and triggers it’s destruction by compliment system or cytotoxicity . autoimmune diseases, transfusion reactions, and hemolytic disease
C) What happens during a transfusion reaction?
The antigens of others blood are attacked by antibodies and result in killing the rbs’s wich release hemoglobin and peices of cells can cause clotts resulting in fever,damaging kidney, along with respiratory and digestive problems
D) How are blood types cross-matched in a clinical setting? [Table 17.2}
blood of donor mixed with recipient and if clumping they will not match
E) How is the Rh antigen different from the ABO system?
the rh negative do not have natural antibodies to rh antigens. These develop when they are exposed to rh positive cells.
F) When can a Rh-negative women become sensitized to the Rh antigen?
during childbirth(placenta ruptures) the babies rh positive antigens
G) What is Hemolytic disease of a newborn and how does it happen? [Figure 17.4]
when a infant’s mother has developed rh antibodies an so blood passed through the placenta will attack the baby
H) When is the medication RhoGAM used?
This is anti rh antibodies. injected during pregnancy and shortly after the babay is born.. the anti rh antibodies bind to the rh positive erythrocytes that may have entered the mothers blood stream preventing cells from initiating immune response.
A) What are immune complexes and what do they cause? [Figure 17.5 and Immune Complex Type 3 Hypersensitivity video]
cause type 3 hypersensitivities.
consisting of IgG or IgM antibodies bound to a soluable antigen. These are removed by phagocytes wich Fc receptors lines with the Fc region on antigen.
B) What is disseminated intravascular coagulation and what causes it?
When the large immune complexes form a clot and then and block small blood vessels leading to organ failure.